About Antheia
Antheia manufactures Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs) for essential medicines. It uses a biosynthesis platform to produce these pharmaceutical ingredients. Antheia supports pharmaceutical partners from development through regulatory submission.
Company Details
Corporate & Operational Profile
Web & Domain Identity
Social & Network Presence
Company Milestones & Timeline
- Capital Raise
Raised $24,000,000 · Series-B+
fundraisingfox.com
- Capital Raise
Raised $56,000,000 · Series-B+
fundraisingfox.com
- Capital Raise
Raised $73,000,000 · Series-B+
- Milestone
X account created (@antheiabio)
360 followers
- Milestone
Company founded
Menlo Park, United States
- Milestone
Website domain registered
antheia.bio
Investors & Backers
Funding History
Founders & Leadership
Chris Savile
Vice President of Business Development and Partnerships
Christina Smolke
Co-Founder & CEO
Eric d’Esparbes
Chief Financial Officer
Heidi Pucel
Chief People Officer
Isis Trenchard
Founder
Kristy Hawkins
Co-Founder & CSO
Pavel Aronov
Senior Director of Bioanalytics
Zack McGahey
Chief Operating Officer
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Hexagon Bio
hexagonbio.com
RefloDx
reflodx.com
HeyVoli
heyvoli.com
CureBay
curebay.com
4Tissue
4tissue.com